Clinical Trial Update: Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing postoperative carbon ion radiotherapy for thymic epithelial tumors with residual disease. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Epithelial Tumor

Snippet

Sponsor: Jian Chen | Conditions: Thymic Epithelial Tumor, Radiotherapy Side Effect | Phase 2 | Status: RECRUITING